Orciprenaline sulfate
A beta-2 adrenergic agonist used in the treatment of asthma and bronchial spasm. (In Vitro) :Metaproterenol (10 μM; 74 hours; THP-1 cells and bone marrow macrophages) treatment enhances β-arrestin2 and its interaction with IκBα in high glucose-induced THP-1 cells and bone marrow macrophages.Metaproterenol (10 μM; 74 hours; THP-1 cells and bone marrow macrophages) treatment leads to downregulation of NF-κB in high glucose-induced THP-1 cells and bone marrow macrophages. (In Vivo) :Treatment of Zucker diabetic fatty rats with Metaproterenol for 12 weeks attenuates monocyte activation as well as pro-inflammatory and pro-fibrotic responses in the kidneys and heart. Thus, Metaproterenol might has protective effects against diabetic renal and cardiovascular complications.
Product Specifications
CAS Number
5874-97-5
Product Name Alternative
Dl-Metaproterenol | dl-Orciprenaline
Field of Research
Pharmacology & Drug Discovery
Purity
>98% (HPLC)
Solubility
DMSO: 10 mM
Smiles
OC1=CC (OS (=O) (O) =O) =CC (C (O) CNC (C) C) =C1
Molecular Formula
C11H17NO3·0·5H2O4S
Molecular Weight
260.3
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
3-hydroxy-5- (1-hydroxy-2- (isopropylamino) ethyl) phenyl hydrogen sulfate
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog